Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | TYMS | P04818 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5080661 | 0.83 | CYP1A2 (0.36) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL24842368 | 0.83 | HSD17B1 (0.39) | CYP1A2PDK2 | |
| SCHEMBL5084434 | 0.82 | CYP1A2 (0.42) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL2965605 | 0.82 | PDK2 (0.39) | PDK2 | |
| SCHEMBL25585945 | 0.80 | LPL (0.36) | CYP1A2PDK2 | |
| SCHEMBL26860176 | 0.80 | LPL (0.36) | CYP1A2PDK2 | |
| SCHEMBL5552172 | 0.79 | ALOX5 (0.46) | PDK2CES1 | |
| SCHEMBL19103103 | 0.78 | S1PR5 (0.32) | — | |
| SCHEMBL5084422 | 0.78 | CYP1A2 (0.43) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL12560767 | 0.78 | CYP2A6 (0.38) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080299294-A1 | ANTHRACENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | Yen, Feng Wen (TW) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299294-A1 | ANTHRACENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | ARL1, ARNT, AHR | ERBB2 2700/4885CYP1A2 26/4885FYN 4281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.